Metformin inhibits leptin-induced growth and migration of glioblastoma cells

Oncology Letters

Volumn 4, Issue 5, 2012, Pages 1077-1081

  Ferla, Rita ^a   Haspinger, Eva ^a,b   Surmacz, Eva ^a  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

AMPK; Glioblastoma; Leptin; Metformin; Migration; Proliferation

Indexed keywords

CYTOKINE; HORMONE RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; LEPTIN RECEPTOR; METFORMIN; PROTEIN KINASE B; STAT3 PROTEIN;

ARTICLE; BLOOD BRAIN BARRIER; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; GLIOBLASTOMA; HUMAN; HUMAN CELL; UPREGULATION;

EID: 84866107225     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.843     Document Type: Article

References (35)

1. Bosi E: Metformin-the gold standard in type 2 diabetes: what does the evidence tell us? Diabetes Obes Metab 11 Suppl 2: 3-8, 2009.
2. Ramachandran A and Snehalatha C: Diabetes prevention programs. Med Clin North Am 95: 353-372, viii, 2011.
3. Boyle JG, Salt IP and McKay GA: Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabet Med 27: 1097-1106, 2010.
4. Janjetovic K, Vucicevic L, Misirkic M, et al: Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt. Eur J Pharmacol 651: 41-50, 2011.
5. Miller RA and Birnbaum MJ: An energetic tale of AMPK-independent effects of metformin. J Clin Invest 120: 2267-2270, 2010.
6. Hardie DG: The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 117: 5479-5487, 2004.
7. Jalving M, Gietema JA, Lefrandt JD, et al: Metformin: taking away the candy for cancer? Eur J Cancer 46: 2369-2380, 2010.
8. Anisimov VN: Metformin for aging and cancer prevention. Aging (Albany NY) 2: 760-774, 2010.
9. Ben Sahra I, Le Marchand-Brustel Y, Tanti JF and Bost F: Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther 9: 1092-1099, 2010.
10. Gonzalez-Angulo AM and Meric-Bernstam F: Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res 16: 1695-1700, 2010.
11. Kourelis TV and Siegel RD: Metformin and cancer: new applications for an old drug. Med Oncol 29: 1314-1327, 2012.
12. Pollak M: Metformin and other biguanides in oncology: advancing the research agenda. Cancer Prev Res (Phila) 3: 1060-1065, 2010.
13. Hosono K, Endo H, Takahashi H, et al: Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prev Res (Phila) 3: 1077-1083, 2010.
14. Eyal S, Hsiao P and Unadkat JD: Drug interactions at the blood-brain barrier: fact or fantasy? Pharmacol Ther 123: 80-104, 2009.
15. Guo D, Cloughesy TF, Radu CG and Mischel PS: AMPK: A metabolic checkpoint that regulates the growth of EGFR activated glioblastomas. Cell Cycle 9: 211-212, 2010.
16. Isakovic A, Harhaji L, Stevanovic D, et al: Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell Mol Life Sci 64: 1290-1302, 2007.
17. Beckner ME, Gobbel GT, Abounader R, et al: Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis. Lab Invest 85: 1457-1470, 2005.
18. Zhang F, Chen Y, Heiman M and Dimarchi R: Leptin: structure, function and biology. Vitam Horm 71: 345-372, 2005.
19. Scolaro L, Cassone, M, Kolaczynski, JW, Otvos L Jr and SurmaczE: Leptin-based therapeutics. Expert Rev Endocrinol Metab 5: 875-889, 2010.
20. Riolfi M, Ferla R, Del Valle L, et al: Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy. Brain Pathol 20: 481-489, 2010.
21. Garofalo C and Surmacz E: Leptin and cancer. J Cell Physiol 207: 12-22, 2006.
22. Yeh WL, Lu DY, Lee MJ and Fu WM: Leptin induces migration and invasion of glioma cells through MMP-13 production. Glia 57: 454-464, 2009.
23. Hardie DG: AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 32 (Suppl4): S7-S12, 2008.
24. Luo Z, Zang M and Guo W: AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol 6: 457-470, 2010.
25. Tang T, Lord JM, Norman RJ, Yasmin E and Balen AH: Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev CD003053, 2009.
26. Berezowska S, Diermeier-Daucher S, Brockhoff G, et al: Effect of additional inhibition of human epidermal growth factor receptor 2 with the bispecific tyrosine kinase inhibitor AEE788 on the resistance to specific EGFR inhibition in glioma cells. Int J Mol Med 26: 713-721, 2010.
27. Guo D, Hildebrandt IJ, Prins RM, et al: The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proc Natl Acad Sci USA 106: 12932-12937, 2009.
28. Ang C, Guiot MC, Ramanakumar AV, Roberge D and Kavan P: Clinical significance of molecular biomarkers in glioblastoma. Can J Neurol Sci 37: 625-630, 2010.
29. Liu TJ, LaFortune T, Honda T, et al: Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Mol Cancer Ther 6: 1357-1367, 2007.
30. Schlegel J, Piontek G, Budde B, Neff F and Kraus A: The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme. Cancer Lett 158: 103-108, 2000.
31. de la Iglesia N, Puram SV and Bonni A: STAT3 regulation of glioblastoma pathogenesis. Curr Mol Med 9: 580-590, 2009.
32. Zakikhani M, Blouin MJ, Piura E and Pollak MN: Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Res Treat 123: 271-279, 2010.
33. Alimova IN, Liu B, Fan Z, et al: Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 8: 909-915, 2009.
34. Yang J and Holman GD: Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis. Endocrinology 147: 2728-2736, 2006.
35. Sonntag B, Gotte M, Wulfing P, Schuring AN, Kiesel L and GrebRR: Metformin alters insulin signaling and viability of human granulosa cells. Fertil Steril 84 Suppl 2: 1173-1179, 2005.